OBJECTIVE: To investigate the levels of human neutrophil elastase and lymphocyte-derived granzymes A and B in relation to disease severity in children with meningococcal disease. DESIGN: Clinical observational cohort study. SETTING: Paediatric intensive care unit. PATIENTS: All patients with meningococcal disease during the study period were included. MEASUREMENTS AND RESULTS: Blood sampling was done on the day of admission and on days 3 and 7. Assays for elastase and granzymes were done with ELISA. Sixty-one patients were included: 19 having distinct meningitis; 17 meningitis and shock; and 25 fulminant septicaemia. On admission levels of elastase were increased in all patients, being highest in those with fulminant septicaemia and lowest in those with distinct meningitis. Granzyme A (although marginally) and granzyme B levels were only increased in patients with shock. In 20 of the 28 patients admitted for > or = 3 days elastase decreased from admission ("rapid-decrease" group). In the remaining 8 patients, elastase started to decrease after 2 days ("slow-decrease" group). Patients of the "slow-decrease" group had a higher temperature up to day 4, needed more respiratory support (mean airway pressure in cm H2O on days 3 and 4: p=0.02 and p<0.01, respectively), and more circulatory support (>2 inotropic agents on day 3; p=0.04) compared with the "rapid-decrease" group. CONCLUSIONS: Human neutrophil elastase and granzyme B are related with disease severity during the initial phase of meningococcal disease and prolonged neutrophil activation is associated with the extent of organ dysfunction during the period thereafter.
OBJECTIVE: To investigate the levels of humanneutrophil elastase and lymphocyte-derived granzymes A and B in relation to disease severity in children with meningococcal disease. DESIGN: Clinical observational cohort study. SETTING: Paediatric intensive care unit. PATIENTS: All patients with meningococcal disease during the study period were included. MEASUREMENTS AND RESULTS: Blood sampling was done on the day of admission and on days 3 and 7. Assays for elastase and granzymes were done with ELISA. Sixty-one patients were included: 19 having distinct meningitis; 17 meningitis and shock; and 25 fulminant septicaemia. On admission levels of elastase were increased in all patients, being highest in those with fulminant septicaemia and lowest in those with distinct meningitis. Granzyme A (although marginally) and granzyme B levels were only increased in patients with shock. In 20 of the 28 patients admitted for > or = 3 days elastase decreased from admission ("rapid-decrease" group). In the remaining 8 patients, elastase started to decrease after 2 days ("slow-decrease" group). Patients of the "slow-decrease" group had a higher temperature up to day 4, needed more respiratory support (mean airway pressure in cm H2O on days 3 and 4: p=0.02 and p<0.01, respectively), and more circulatory support (>2 inotropic agents on day 3; p=0.04) compared with the "rapid-decrease" group. CONCLUSIONS:Humanneutrophil elastase and granzyme B are related with disease severity during the initial phase of meningococcal disease and prolonged neutrophil activation is associated with the extent of organ dysfunction during the period thereafter.
Authors: R S Hotchkiss; K W Tinsley; P E Swanson; K C Chang; J P Cobb; T G Buchman; S J Korsmeyer; I E Karl Journal: Proc Natl Acad Sci U S A Date: 1999-12-07 Impact factor: 11.205
Authors: J B van Woensel; M H Biezeveld; A M Alders; A J Eerenberg; E Endert; E C Hack; I A von Rosenstiel; T W Kuijpers Journal: J Infect Dis Date: 2001-12-03 Impact factor: 5.226
Authors: F N Lauw; A J Simpson; C E Hack; J M Prins; A M Wolbink; S J van Deventer; W Chaowagul; N J White; T van Der Poll Journal: J Infect Dis Date: 2000-07-06 Impact factor: 5.226
Authors: Peter Andrews; Elie Azoulay; Massimo Antonelli; Laurent Brochard; Christian Brun-Buisson; Geoffrey Dobb; Jean-Yves Fagon; Herwig Gerlach; Johan Groeneveld; Jordi Mancebo; Philipp Metnitz; Stefano Nava; Jerome Pugin; Michael Pinsky; Peter Radermacher; Christian Richard; Robert Tasker Journal: Intensive Care Med Date: 2006-02-18 Impact factor: 17.440
Authors: Job B M van Woensel; Maarten H Biezeveld; C Erik Hack; Albert P Bos; Taco W Kuijpers Journal: Intensive Care Med Date: 2005-07-12 Impact factor: 17.440
Authors: M H Biezeveld; G van Mierlo; R Lutter; I M Kuipers; T Dekker; C E Hack; J W Newburger; T W Kuijpers Journal: Clin Exp Immunol Date: 2005-07 Impact factor: 4.330
Authors: Martine J Hollestelle; Ka Wai Lai; Marcel van Deuren; Peter J Lenting; Philip G de Groot; Tom Sprong; Niels Bovenschen Journal: PLoS One Date: 2011-09-01 Impact factor: 3.240